Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KE.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KE.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FY.8.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.8.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.30NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.56NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.56NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JD.1.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JD.1.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDTNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDTNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.362.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.362.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.48NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.48NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.520NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.520NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.38NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.389NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.389NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.549NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.549NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.43.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.43.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.258.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.521NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.521NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.383NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.383NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.117NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.117NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.157NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.157NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.187NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.187NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.30NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.213NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.213NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used